DERIVATIVES OF INDOLE, THEIR TAUTOMERS, MIXTURES OF THEIR ISOMERS OR SEPARATE ISOMERS AND PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION SHOWING ANTITUMOR OR INHIBITING PROTEIN TYROSINE KINASE ACTIVITY AND METHOD OF INHIBITION OF PROTEIN TYROSINE KINASE-DEPENDING DISEASE OR CONTROL OF ABERRANT GROWTH OF MAMMALIAN OR HUMAN CELLS Russian patent published in 2000 - IPC

Abstract RU 2155187 C2

FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes the novel derivatives of indole of the general formula (I) and their tautomers where R1 is hydrogen, halogen atoms, lower alkyl, hydroxyl, nitro-group, trifluoromethyl, groups OCOR and OR where R means lower alkyl being residue R1 can replace a single group of ring with aza-atom; R2 means groups: (CH2)n-COOH, (CH2)nCONH2, (CH2)n-COOR, (CH2)n-CONHR, (CH2)n-CONRR, (CH2)nCONHCH2Ph, CONHR, CONRR, CONHPh, COPhCOOH, COPhCOOR, (CH2)n-CONHPh or (CH2)n-CONHPhR where R has the above indicated value; Ph means phenyl; n = 1-4; groups COY and SO2Y where Y means unsubstituted phenyl or phenyl substituted with lower alkyl, carboxyl or group OCOR where R has the above indicated value; R3 is hydrogen atom, benzyl; R4 is groups: SH, S0X,S0Q1 Se0Q′ where o = 1, 2 or 3; X is hydrogen atom, lower alkyl, benzyl; Q is 2-thio-indolyl of the general formula (I); Q′ is 2-selenoindolyl of the general formula (I) under condition that if R4 means Se0Q′, then R2 means groups COOR5 where R5 means hydrogen atom or lower alkyl, -CONHR6 where R6 means lower alkyl or (CH2)2-lower dialkyl or group where R2 means amino-group and Ph is phenyl but the following compounds are excluded: 2-(2-thioxo- -3-indolinyl)-acetic acid, 2-(1-methyl-2-thioxo-3-indolinyl)-acetic acid, methyl-2-(2-thioxo-3-indolinyl)acetate, ethyl- -2-(1-methyl-2-thioxo-3-indolinyl)acetate, bis-[methyl- -indolinyl-3-acetate-(2)] disulfide, bis-[indolyl-3-acetic acid-(2)] disulfide, bis-[methylindolyl-3-acetate-(2)] trisulfide, bis-[1-methylindolyl-3-acetic acid-(2)] disulfide, 2,3-dihydro-2-thioxo-1H-indole-3-acetic acid methyl ester and 2-(methylthio)-1H-indole-3-acetic acid methyl ester, mixtures of their isomers or separate isomers and pharmaceutically acceptable salts. Compounds of the formula (I) show valuable pharmacological properties, in part, they can be used as inhibitors of protein tyrosine kinase and an antitumor agent. Invention describes also pharmaceutical composition based on compounds of the formula (I), method of inhibition of protein tyrosine kinase depending disease or control of aberrant growth of mammalian or human cells. EFFECT: valuable medicinal properties of compounds. 4 cl, 3 tbl, 9 ex

Similar patents RU2155187C2

Title Year Author Number
METHODS OF INHIBITION OF TYROSINE KINASE ACTIVITY IN EPIDERMAL GROWTH FACTOR RECEPTORS, BICYCLIC PYRIMIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY INHIBITING ACTIVITY OF TYROSINE KINASE IN EPIDERMAL GROWTH FACTOR RECEPTORS AND COMPOSITION ELICITING CONTRACEPTIVE EFFECT 1995
  • Aleksander Dzhejms Bridzhes
  • Uilliam Aleksander Dehnni
  • Dehvid Fraj
  • Alan Krejker
  • Robert Majer
  • Gordon Uilliam R'Jukastl
  • Ehndrju Mark Tompson
RU2174980C2
METHOD FOR INHIBITING EPIDERMAL GROWTH FACTOR RECEPTOR THYROSINEKINASE, NITROGEN-CONTAINING TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION FOR INTRODUCING EPIDERMAL GROWTH FACTOR RECEPTOR THYROSINEKINASE INHIBITOR LIKE ERB- B2, ERB-B3 OR ERB-B4 AND CONTRACEPTIVE COMPOSITION 1995
  • Aleksander Dzhejms Bridzhes
  • Uilliam Aleksander Dehnni
  • Dehvid Fraj
  • Alan Krejker
  • Robert Majer
  • Gordon Uilliam Rukasl
  • Andru Mark Tompson
  • Khauard Dehniel Khollis Shoualter
RU2158127C2
METHOD OF SYNTHESIS OF (S)-(-)- AND (R)-(+)-ISOMERS OF (5-AMINO-1,2-DIHYDRO-2-METHYL-3-PHENYLPYRIDO-[3,4-B]-PYRAZINE- -7-YL)-CARBAMIDE ACID ETHYL ESTER OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND INTERMEDIATE (S)-(-)- AND (R)-(+)-ISOMERS OF [6-AMINO-4-[[2-(ALKOXYALKYLAMINO)-1-METHYL-2-OXOETHYL]-AMI- -NO]-5-NITRO-2-PYRIDINYL]-CARBAMIDE ACID ETHYL ESTER 1994
  • Om Prakash Goehl[Us]
  • Sham Shridkhar Nikam[In]
RU2098409C1
METHOD OF PREPARING TRANS-6-[SUBSTITUTED PYRROL-1- YL)ALKYL]PYRAN-2-ON DERIVATIVES AND THEIR DIHYDROXY-CONTAINING ACIDS AND SALTS, HYDROXY-, 1,3-DIOXAN- OR PYRROLE-CONTAINING CARBOXYLIC ACIDS AS INTERMEDIATES FOR PREPARING SAID PYRAN-2-ON DERIVATIVES 1994
  • Donal'D Ehjdzhin Batler
  • Tung Van Li
  • Tomas Norman Nanninga
RU2138497C1
2-AMINO-2-PHENYLALKANOL DERIVATIVES, PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM 2009
  • Deni Aleksis
  • Pasho Zhan
  • Dini Kristof
RU2486174C2
1,3-DIOXOINDENE DERIVATIVES, THEREOF PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF OBTAINING THEREOF AND PHARMACEUTICAL ANTIVIRAL COMPOSITION, CONTAINING IT AS ACTIVE INGREDIENT 2012
  • Dzung Jang Sik
  • Li Chong Kgo
  • Choi Ikhl Jang
  • Kim Khae Soo
  • Kim Pil Kho
  • Khan Soo Bong
  • Nehjts Jokhan
  • Tibo Khendrik Jan
RU2566761C2
PYRAZOLE DERIVATIVES APPLIED AS PROTEIN KINASE INHIBITORS 2013
  • Khollik Dzhonatan Dzhejms
  • Dzhouns Styuart Donald
  • Flinn Kler Dzhun
  • Tomas Majkl Dzhordzh
RU2623221C2
FLUOROTAXOLS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD OF PATIENT TREATMENT 1993
  • Shu-Kh'Ju Chen
  • Vittorio Farina
  • Dolatraj Vias
  • Dzhojdip Kant
RU2131874C1
3-SUBSTITUTED OXINDOLE DERIVATIVES AS MODULATORS OF POTASSIUM CHANNELS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT 1996
  • Pijasena Khevavasam
  • Nikolas A. Minvell
  • Valentin K. Gribkov
RU2165925C2
SULFAMIC ACID ESTERS, PHARMACEUTICAL COMPOSITION FOR CONTROL OF CHOLESTEROL CONCENTRATION, METHOD OF TREATMENT OF PATIENTS WITH HYPERCHOLESTEROLEMIA, METHOD OF TREATMENT OF PATIENTS WITH ATHEROSCLEROSIS 1994
  • Khelen Tsenvej Li
  • Dzhozef Armend Pikard
  • Drago Robert Sliskovits
  • Vendell Virendzhe
RU2137756C1

RU 2 155 187 C2

Authors

Dobrasin Ehllen Mira

Shovol'Ter Khovord Dehniel' Khollis

Denni Uilliehm Aleksander

Pal'Mer Brajn Desmond

Rjukasel' Gordon Uilliehm

Tersel' Moehna

Tomson Ehndrju Mark

Dates

2000-08-27Published

1993-08-02Filed